Unlock instant, AI-driven research and patent intelligence for your innovation.

A thermosensitive gel matrix and its preparation method and application

A temperature-sensitive gel matrix and a technology for preparing drugs, which are used in pharmaceutical formulations, medical preparations with inactive ingredients, and aerosol delivery, etc., can solve the problems of fast drug release rate, easy depolymerization, and no research reports on Soluplus temperature-sensitive gel. , to achieve the effect of convenient administration

Active Publication Date: 2019-10-29
ZHEJIANG UNIV OF TECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although adding poloxamer 188 can increase the phase transition temperature of poloxamer 407, or adding a thickener can improve the mechanical strength of the gel, but the in vivo stability of poloxamer 407 thermosensitive gel is poor and easy to depolymerize, resulting in Drug release rate in vivo is too fast (McKenzie M, Betts D, Suh A, Bui K, Kim LD, Cho H. Hydrogel-based drug delivery systems for poorly water-soluble drugs. Molecules. 2015, 20(11): 20397-408)
So far there is no research report on Soluplus as a thermosensitive gel

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A thermosensitive gel matrix and its preparation method and application
  • A thermosensitive gel matrix and its preparation method and application
  • A thermosensitive gel matrix and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1: Comparison of the gelation temperature of Soluplus and Poloxamer 407 systems with the same solid content

[0047] Reagents required: Soluplus, Poloxamer 407, 50 mM phosphate buffer.

[0048] Preparation of 50mM phosphate buffer: weigh NaH 2 PO 4 7.8g, add 1000mL degassed water for injection to dissolve, and then adjust the pH to 7.4 with NaOH.

[0049] Precisely weigh 20 g each of Soluplus and Poloxamer 407, add 50 mM phosphate buffer to 100 g, and disperse at 4°C to prepare a dispersion system with a solid content of 20%. Using the overturning method, put the test product in the glass bottle, start to heat up from a water bath at 15°C, the temperature rise rate is 1.0°C / min, and maintain 2min at each temperature point, tilt the glass bottle at 60°, until the test sample remains stagnant for 30s The temperature is the gelation temperature.

[0050] From figure 1 It can be seen that the Soluplus blank gel with 20% solid content is a light blue opalescent n...

Embodiment 2

[0051] Example 2: Comparison of the gelation temperature of Soluplus and Poloxamer 407 systems with different solid contents

[0052] Reagents required: Soluplus, Poloxamer 407, water.

[0053] Accurately weigh the appropriate amount of Soluplus and Poloxamer 407 respectively, add water to 100g each, and disperse at 4°C to prepare a dispersion system. Using the flipping method, put the test product in the glass bottle, start to heat up from a water bath at 15°C, the temperature rise rate is 1.0°C / min, and maintain each temperature point for 2min, tilt the glass bottle at 60°, until the test sample remains stagnant for 30s The temperature is the gelation temperature.

[0054] The results showed that if the concentration of Soluplus is lower than 5%, it will not gel even if the temperature reaches 70°C; if the concentration is greater than 50%, it will become jelly at 15°C and cannot be injected. If the concentration of poloxamer 407 is lower than 15%, it cannot gel at 70°C; i...

Embodiment 3

[0055] Example 3: Comparison of the gelation temperature of Soluplus and Poloxamer 407 systems in different media

[0056] Reagents required: Soluplus, Poloxamer 407, water, 50 mM phosphate buffer, 0.9 wt% NaCl solution, isotonic phosphate buffer.

[0057] The preparation method of 50mM phosphate buffer solution is the same as that in Example 1.

[0058] Preparation of isotonic phosphate buffer: weigh 8g of NaCl, KH 2 PO 4 0.2g, Na 2 HPO 4 12H 2 Add 2.9g of O and 0.2g of KCl into the container, then add 1000mL of degassed purified water to dissolve, and adjust the pH to 7.4 with NaOH.

[0059] Accurately weigh the appropriate amount of Soluplus and Poloxamer 407 respectively, add different media to 100g, and disperse at 4°C to prepare a dispersion system. Using the flipping method, put the test product in the glass bottle, start to heat up from a water bath at 15°C, the temperature rise rate is 1.0°C / min, and maintain each temperature point for 2min, tilt the glass bott...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a temperature-sensitive gel matrix and a preparation method thereof. The temperature-sensitive gel matrix mainly comprises Soluplus and a water phase; the water phase is compounded by dissolving an isoosmotic adjusting agent and / or a pH adjusting agent into water, the osmotic pressure of the water phase is 0-400 mOsmol / kg, and the pH value is 3.0-9.0; based on the Soluplus and the water phase, the weight percentage content of the Soluplus is 8-50%, and the balance is the water phase. The temperature-sensitive gel matrix can be applied as a drug carrier; compared with the congealing temperature of temperature-sensitive gel poloxamer 407, the phase change temperature of the temperature-sensitive gel matrix is closer to the body temperature, so that a drug can be administrated conveniently, strength of gel formed inside the body is higher than strength of the temperature-sensitive gel poloxamer 407, and after hypodermic injection is conducted, slow drug release can be maintained for seven days or more, while slow drug release of poloxamer 407 can only be maintained for about one day.

Description

[0001] (1) Technical field [0002] The present invention relates to a temperature-sensitive gel matrix and its preparation method and application, in particular to a temperature-sensitive gel matrix based on polyethylene caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (Soluplus) and its preparation method, and Application as a drug carrier. [0003] (2) Background technology [0004] Thermosensitive gel refers to a new type of drug-loading system that is in a fluid state at room temperature and undergoes a rapid phase transition to form a gel at body temperature. Poloxamer 407 (Pluronic F127 or Lutrol F127 or Kolliphor P407, referred to as F127 or P407) is a tri-block copolymer of polyoxyethylene-polyoxypropylene-polyoxyethylene (101:56:101), with an average molecular weight of 9,840-14,600 g / mol, is a commonly used temperature-sensitive gel matrix. It has been reported in the literature that when the concentration is 18%, the phase transition temperature i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/06A61K47/34
CPCA61K9/0002A61K9/0019A61K9/06A61K47/34
Inventor 熊素彬吴慧敏陈芳尹小东
Owner ZHEJIANG UNIV OF TECH